Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q57121731)
Watch
English
Prostate cancer
scientific article published in The Lancet
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
26074382
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26074382%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 February 2020
review article
1 reference
stated in
Europe PubMed Central
title
Prostate cancer
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
26074382
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26074382%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 February 2020
main subject
phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase
0 references
prostate cancer
1 reference
based on heuristic
inferred from title
author
Gerhardt Attard
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
26074382
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26074382%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 February 2020
Rosalind Eeles
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
26074382
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26074382%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 February 2020
Ian F. Tannock
series ordinal
6
object named as
Ian Tannock
1 reference
stated in
Europe PubMed Central
PubMed ID
26074382
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26074382%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 February 2020
Charles G. Drake
series ordinal
7
object named as
Charles G Drake
1 reference
stated in
Europe PubMed Central
PubMed ID
26074382
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26074382%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 February 2020
author name string
Chris Parker
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
26074382
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26074382%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 February 2020
Fritz Schröder
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
26074382
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26074382%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 February 2020
Scott A Tomlins
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
26074382
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26074382%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 February 2020
Johann S de Bono
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
26074382
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26074382%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 February 2020
language of work or name
English
0 references
publication date
11 June 2015
1 reference
stated in
Europe PubMed Central
PubMed ID
26074382
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26074382%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 February 2020
published in
The Lancet
1 reference
stated in
Europe PubMed Central
PubMed ID
26074382
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26074382%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 February 2020
volume
387
1 reference
stated in
Europe PubMed Central
PubMed ID
26074382
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26074382%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 February 2020
issue
10013
1 reference
stated in
Europe PubMed Central
PubMed ID
26074382
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26074382%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 February 2020
page(s)
70-82
1 reference
stated in
Europe PubMed Central
PubMed ID
26074382
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26074382%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 February 2020
cites work
International comparisons of cumulative risk of breast and prostate cancer, from cancer incidence in five continents Vol. VIII.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cancer incidence among Korean-American immigrants in the United States and native Koreans in South Korea.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In vivo amplification of the androgen receptor gene and progression of human prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Molecular determinants of resistance to antiandrogen therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Distinct transcriptional programs mediated by the ligand-dependent full-length androgen receptor and its splice variants in castration-resistant prostate cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Systematic Population-Based Assessment of Cancer Risk in First-Degree Relatives of Cancer Probands
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The complex genetic epidemiology of prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A systematic review and meta-analysis of familial prostate cancer risk
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Familial breast cancer in the family-cancer database
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Studies of genetic factors in prostate cancer in a twin population
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mendelian inheritance of familial prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Transmission disequilibrium, family controls, and great expectations
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Germline mutations in HOXB13 and prostate-cancer risk
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The genetic epidemiology of prostate cancer and its clinical implications
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Principles for the post-GWAS functional characterization of cancer risk loci
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cancer risks in BRCA2 mutation carriers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Variation in cancer risks, by mutation position, in BRCA2 mutation carriers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Germline BRCA1 mutations increase prostate cancer risk
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A novel founder CHEK2 mutation is associated with increased prostate cancer risk.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A recurrent mutation in PALB2 in Finnish cancer families.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Response: Reading between the lines of cancer screening trials: using modeling to understand the evidence
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Quality-of-life effects of prostate-specific antigen screening.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Screening and prostate-cancer mortality in a randomized European study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prostate-cancer mortality at 11 years of follow-up
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Screening for prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Performance of the prostate cancer antigen 3 (PCA3) gene and prostate-specific antigen in prescreened men: exploring the value of PCA3 for a first-line diagnostic test
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prospective Assessment of Prostate Cancer Aggressiveness Using 3-T Diffusion-Weighted Magnetic Resonance Imaging–Guided Biopsies Versus a Systematic 10-Core Transrectal Ultrasound Prostate Biopsy Cohort
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Punctuated evolution of prostate cancer genomes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Triggers for genomic rearrangements: insights into genomic, cellular and environmental influences
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The genomic complexity of primary human prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The mutational landscape of lethal castration-resistant prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The mitochondrial and autosomal mutation landscapes of prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New strategies in prostate cancer: translating genomics into the clinic
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Integrative genomic profiling of human prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Complex patterns of ETS gene alteration arise during cancer development in the human prostate
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Common gene rearrangements in prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identification of a cell of origin for human prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prostate cancer originating in basal cells progresses to adenocarcinoma propagated by luminal-like cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A luminal epithelial stem cell that is a cell of origin for prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Genome-wide DNA methylation events in TMPRSS2-ERG fusion-negative prostate cancers implicate an EZH2-dependent mechanism with miR-26a hypermethylation.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Distinct genomic alterations in prostate cancers in Chinese and Western populations suggest alternative pathways of prostate carcinogenesis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Novel dual-color immunohistochemical methods for detecting ERG-PTEN and ERG-SPINK1 status in prostate carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical potential of the ERG oncoprotein in prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Correlation of urine TMPRSS2:ERG and PCA3 to ERG+ and total prostate cancer burden
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Exome sequencing of prostate cancer supports the hypothesis of independent tumour origins
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evidence of independent origin of multiple tumors from patients with prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Molecular sampling of prostate cancer: a dilemma for predicting disease progression
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Genomic strategy for targeting therapy in castration-resistant prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Androgen receptor signaling in circulating tumor cells as a marker of hormonally responsive prostate cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Active surveillance: towards a new paradigm in the management of early prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Medium-term outcomes of active surveillance for localised prostate cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Radical prostatectomy versus watchful waiting in early prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Radical prostatectomy versus observation for localized prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Radical prostatectomy or watchful waiting in early prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neo-adjuvant and adjuvant hormone therapy for localised prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Radiotherapy and short-term androgen deprivation for localized prostate cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Duration of androgen suppression in the treatment of prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sex or survival: short-term versus long-term androgen deprivation in patients with locally advanced prostate cancer treated with radiotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Abiraterone in metastatic prostate cancer without previous chemotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Enzalutamide in metastatic prostate cancer before chemotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Castration-dependent pharmacokinetics of docetaxel in patients with prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of the androgen receptor as a novel mechanism of taxol chemotherapy in prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antitumour activity of docetaxel following treatment with the CYP17A1 inhibitor abiraterone: clinical evidence for cross-resistance?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Activity of cabazitaxel in castration-resistant prostate cancer progressing after docetaxel and next-generation endocrine agents.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiandrogen withdrawal alone or in combination with ketoconazole in androgen-independent prostate cancer patients: a phase III trial (CALGB 9583).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I clinical trial of the CYP17 inhibitor abiraterone acetate demonstrating clinical activity in patients with castration-resistant prostate cancer who received prior ketoconazole therapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Abiraterone and increased survival in metastatic prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant prostate cancer: exploratory analysis of data from the COU-AA-301 randomis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of abiraterone acetate on fatigue in patients with metastatic castration-resistant prostate cancer after docetaxel chemotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interactions of abiraterone, eplerenone, and prednisolone with wild-type and mutant androgen receptor: a rationale for increasing abiraterone exposure or combining with MDV3100.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Resistance to CYP17A1 inhibition with abiraterone in castration-resistant prostate cancer: induction of steroidogenesis and androgen receptor splice variants
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Development of a second-generation antiandrogen for treatment of advanced prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Increased survival with enzalutamide in prostate cancer after chemotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Overcoming mutation-based resistance to antiandrogens with rational drug design
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical activity of abiraterone acetate in patients with metastatic castration-resistant prostate cancer progressing after enzalutamide
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antitumour activity of enzalutamide (MDV3100) in patients with metastatic castration-resistant prostate cancer (CRPC) pre-treated with docetaxel and abiraterone
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sipuleucel-T immunotherapy for castration-resistant prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Alpha emitter radium-223 and survival in metastatic prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cabazitaxel for the second-line treatment of metastatic hormone-refractory prostate cancer: a NICE single technology appraisal
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
NICE guidance on abiraterone for castration-resistant metastatic prostate cancer previously treated with a docetaxel-containing regimen
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Zoledronic acid: a pharmacoeconomic review of its use in the management of bone metastases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a cost-effectiveness analysis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interdisciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961947-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0140-6736(14)61947-4
1 reference
stated in
Europe PubMed Central
PubMed ID
26074382
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26074382%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 February 2020
PubMed ID
26074382
1 reference
stated in
Europe PubMed Central
PubMed ID
26074382
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26074382%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 February 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit